Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
08/24/1999 | US5942394 Detection of protozoan parasites |
08/24/1999 | US5942393 Method for the detection of the presence or absence of methylthioadenosine phosphorylase (MTASE) in a cell sample by detection of the presence or absence of MTASE encoding nucleic acid in the cell sample |
08/24/1999 | US5942392 Genetic markers used jointly for the diagnosis of Alzheimer's disease, and diagnostic method and kit |
08/24/1999 | US5942391 Detecting target nucleic acid from pathogenic microorganisms or viruses by hybridizing nucleic acid to capture probes in the presence of ligand coated magnetic beads forming a complex of the target nucleic acid, beads and probe |
08/24/1999 | US5942390 Screening for differentials in allele 2 polynucleotide or fragments containing tandem repeat polymorphism at intron 2 |
08/24/1999 | US5942388 Electrobiochemical method and system for the determination of an analyte which is a member of a recognition pair in a liquid medium, and electrodes thereof |
08/24/1999 | US5942385 Method for molecular diagnosis of tumor angiogenesis and metastasis |
08/24/1999 | US5942236 Potential vaccine for use against lyme disease to induce a protective immune response in humans by administrating a purified immunogenic outer surface lipoprotein of micelle form |
08/24/1999 | US5942102 Electrochemical method |
08/24/1999 | US5941774 Image display gaming system and gaming house management system |
08/24/1999 | CA2248972A1 Novel compounds |
08/20/1999 | CA2249653A1 Novel compounds |
08/19/1999 | WO1999041615A1 Coagulant activity assessment in presence of metal ions |
08/19/1999 | WO1999041614A2 Method for detecting intimin producing microorganisms |
08/19/1999 | WO1999041613A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
08/19/1999 | WO1999041607A2 Fluorescent energy for elucidating the 3-d structure of biological macromolecules |
08/19/1999 | WO1999041415A1 Transposable element-anchored, amplification method for isolation and identification of tagged genes |
08/19/1999 | WO1999041414A1 Methods for identifying nucleic acid mutations using mismatch modification |
08/19/1999 | WO1999041413A2 Prostate cancer drug screening |
08/19/1999 | WO1999041412A1 A novel npg-1 gene that is differentially expressed in prostate tumors |
08/19/1999 | WO1999041411A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
08/19/1999 | WO1999041410A1 Methods for dna amplification and sequencing |
08/19/1999 | WO1999041409A1 CHROMOGENIC SUBSTRATES FOR THE DETECTION OF $i(SALMONELLA) |
08/19/1999 | WO1999041408A1 Microbial assay |
08/19/1999 | WO1999041407A1 Method for developing a pharmaceutical active ingredient |
08/19/1999 | WO1999041406A1 Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis |
08/19/1999 | WO1999041402A2 Targeting of genetic vaccine vectors |
08/19/1999 | WO1999041389A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
08/19/1999 | WO1999041388A2 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides |
08/19/1999 | WO1999041387A2 Prostate-associated serine protease |
08/19/1999 | WO1999041386A2 Novel endo-xylogalacturonase |
08/19/1999 | WO1999041384A1 Splice variants of p101 protein |
08/19/1999 | WO1999041380A1 THE REGULATORY SEQUENCE OF η-4 GERMLINE (GL) TRANSCRIPT AND ITS APPLICATIONS |
08/19/1999 | WO1999041379A2 Members of the d52 gene family |
08/19/1999 | WO1999041378A1 Members of the d52 gene family |
08/19/1999 | WO1999041377A1 Novel cystine knot protein and materials and methods for making it |
08/19/1999 | WO1999041375A2 Human receptor proteins |
08/19/1999 | WO1999041374A2 Human short-chain tnf-receptor family protein |
08/19/1999 | WO1999041373A2 Human transport-associated molecules |
08/19/1999 | WO1999041371A1 Use of ribozymes for functionating genes |
08/19/1999 | WO1999041370A1 Cea/nca-based differentiation cancer therapy |
08/19/1999 | WO1999041369A2 Genetic vaccine vector engineering |
08/19/1999 | WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines |
08/19/1999 | WO1999041364A2 Compositions and methods for wound healing |
08/19/1999 | WO1999041362A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically |
08/19/1999 | WO1999041360A1 Method for the development of an hiv vaccine |
08/19/1999 | WO1999041278A1 Cyclic peptide inhibitors of pla2 |
08/19/1999 | WO1999041273A2 Pna and dna conjugates and methods for preparation thereof |
08/19/1999 | WO1999041271A1 High affinity nucleic acid ligands of complement system proteins |
08/19/1999 | WO1999041270A1 Compositions and methods for the inhibition of muc-5 mucin gene expression |
08/19/1999 | WO1999041007A2 Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
08/19/1999 | WO1999040989A1 Natural products from terrestrial and marine sources, and drug discovery based thereon |
08/19/1999 | WO1999040946A2 Methods and compositions for modulating leptin activity |
08/19/1999 | WO1999040789A1 Methods and compounds for the genetic treatment of hyperlipidemia |
08/19/1999 | WO1999036432A3 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
08/19/1999 | WO1999033998A3 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
08/19/1999 | WO1999031269A3 New candida albicans kre9 and uses thereof |
08/19/1999 | WO1999031255A3 Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes |
08/19/1999 | WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof |
08/19/1999 | WO1999024621A3 Methods and compositions for detection of specific nucleotide sequences |
08/19/1999 | WO1999023236A9 Method of dna shuffling |
08/19/1999 | WO1999023227A3 Hyaluronan synthase gene and uses thereof |
08/19/1999 | WO1999023108A9 Inducible phosphofructokinase and the warburg effect |
08/19/1999 | WO1999016907A3 Reagent and method for attaching target molecules to a surface |
08/19/1999 | WO1999015894A3 Method of identification of leads or active compounds |
08/19/1999 | WO1999014355A3 Highly affine nucleic acid molecules, production and application of same |
08/19/1999 | WO1999005159A3 Staphylococcus specific nucleic acid molecule, test kit and utilization of the nucleic acid molecule and test kit |
08/19/1999 | WO1999004266A3 Interactions of atm, atr or dna-pk with p53 |
08/19/1999 | WO1997036994A8 Sensor and modified membrane for the sensor |
08/19/1999 | DE19807608A1 Measuring level of protein biosynthesis using photoprotein loaded with co-factor during translation as reporter for screening for biologically active compounds |
08/19/1999 | DE19806274A1 Detecting Aspergillus nucleic acid in body samples by two-step polymerase chain reaction, for diagnosing aspergillosis |
08/19/1999 | DE19802377A1 Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs Use of inhibitors for the treatment of RTK function-related disorders, particularly cancer |
08/19/1999 | CA2521289A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
08/19/1999 | CA2323011A1 Method for the development of an hiv vaccine |
08/19/1999 | CA2321259A1 Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis |
08/19/1999 | CA2321105A1 Human short-chain tnf-receptor family protein |
08/19/1999 | CA2320965A1 Methods and compounds for the genetic treatment of hyperlipidemia |
08/19/1999 | CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines |
08/19/1999 | CA2320806A1 Members of the d52 gene family |
08/19/1999 | CA2320784A1 Members of the d52 gene family |
08/19/1999 | CA2320753A1 Method for detecting intimin producing microorganisms |
08/19/1999 | CA2320626A1 Genetic vaccine vector engineering |
08/19/1999 | CA2320431A1 Targeting of genetic vaccine vectors |
08/19/1999 | CA2320427A1 Human receptor proteins |
08/19/1999 | CA2320424A1 Human transport-associated molecules |
08/19/1999 | CA2320422A1 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides |
08/19/1999 | CA2320391A1 Novel cystine knot protein and materials and methods for making it |
08/19/1999 | CA2320389A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically |
08/19/1999 | CA2320226A1 Methods and compositions for modulating leptin activity |
08/19/1999 | CA2320031A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
08/19/1999 | CA2319065A1 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
08/19/1999 | CA2312991A1 Prostate-associated serine protease |
08/18/1999 | EP0935756A2 Monitoring reactivity of thyroid peroxidase autoantibodies |
08/18/1999 | EP0935753A1 Assay and cell line for the identification of growth hormone mimetics |
08/18/1999 | EP0935752A1 Methods for in vitro determination of erythropoietin bioactivity |
08/18/1999 | EP0935679A1 Method for chromosome classification by decorrelation statistical analysis and hardware therefore |
08/18/1999 | EP0935678A1 METHODS FOR TREATING BIPOLAR MOOD DISORDER ASSOCIATED WITH MARKERS ON CHROMOSOMES 18p |
08/18/1999 | EP0935676A2 Method of identifying cytochrome p450 |
08/18/1999 | EP0935675A1 Nucleic acid primers and probes for detecting oncogenic human papillomaviruses |
08/18/1999 | EP0935674A1 Method for diagnosis of genetic diseases by molecular combing and diagnosis box |